Chigusa Morizane Selected Research

Chigusa Morizane Research Topics

Disease

49	Neoplasms (Cancer) 12/2022 - 09/2004
35	Pancreatic Neoplasms (Pancreatic Cancer) 08/2022 - 01/2005
26	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 02/2005
25	Biliary Tract Neoplasms (Biliary Tract Cancer) 06/2022 - 01/2003
8	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 10/2013
8	Neutropenia 01/2021 - 02/2005
8	Adenocarcinoma 10/2020 - 01/2005
8	Neoplasm Metastasis (Metastasis) 05/2019 - 12/2007
6	Neuroendocrine Carcinoma 01/2020 - 04/2010
6	Thrombocytopenia (Thrombopenia) 06/2017 - 02/2005
5	Carcinoma (Carcinomatosis) 10/2020 - 08/2005
5	Leukopenia 06/2017 - 02/2005
4	Cholangiocarcinoma 11/2021 - 07/2008
4	Disease Progression 07/2020 - 04/2014
3	Pathologic Constriction (Stenosis) 12/2022 - 01/2008
3	Stomach Neoplasms (Stomach Cancer) 07/2022 - 11/2020
3	Exanthema (Rash) 01/2019 - 10/2012
3	Anorexia 01/2019 - 06/2006
2	Fever (Fevers) 09/2022 - 04/2014
2	Nausea 01/2022 - 06/2006
2	Acinar Cell Carcinoma 01/2021 - 11/2009
2	Epithelioid Hemangioendothelioma 01/2021 - 10/2018
2	Ascites 01/2021 - 12/2007
2	Hepatitis 01/2019 - 09/2012
2	Stomatitis 01/2019 - 10/2012
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2015 - 04/2010
2	Drug-Related Side Effects and Adverse Reactions 10/2014 - 10/2012
2	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2012 - 08/2010
2	Pneumonia (Pneumonitis) 10/2012 - 01/2009
1	Encephalitis (Encephalitis, Rasmussen) 09/2022
1	Hyperphosphatemia 07/2022
1	Fistula 04/2022

Drug/Important Bio-Agent (IBA)

39	Gemcitabine FDA Link 01/2022 - 01/2005
24	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2003
9	PlatinumIBA 01/2021 - 08/2015
8	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 03/2010
8	Fluorouracil (Carac)FDA LinkGeneric 06/2017 - 01/2003
6	Pharmaceutical PreparationsIBA 06/2022 - 06/2006
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2017 - 02/2005
5	Biomarkers (Surrogate Marker)IBA 12/2020 - 10/2013
5	Alanine Transaminase (SGPT)IBA 06/2017 - 02/2005
4	folfirinoxIBA 08/2022 - 02/2015
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2012
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 09/2012
4	C-Reactive ProteinIBA 01/2016 - 01/2009
4	TegafurIBA 03/2011 - 08/2005
4	Epirubicin (Ellence)FDA LinkGeneric 07/2008 - 01/2003
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 07/2015
3	Protein Subunit VaccinesIBA 01/2021 - 12/2010
3	Peptides (Polypeptides)IBA 01/2021 - 12/2009
3	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2017 - 02/2005
3	orantinib (SU6668)IBA 10/2014 - 02/2011
3	UracilIBA 03/2011 - 08/2005
2	SteroidsIBA 09/2022 - 10/2020
2	Bevacizumab (Avastin)FDA Link 09/2022 - 08/2018
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 07/2022 - 02/2011
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 11/2021 - 01/2021
2	Everolimus FDA Link 11/2021 - 10/2012
2	Histone Deacetylase InhibitorsIBA 01/2021 - 01/2019
2	resminostatIBA 01/2021 - 01/2019
2	VaccinesIBA 01/2021 - 01/2011
2	GlypicansIBA 01/2021 - 04/2014
2	Circulating Tumor DNAIBA 12/2020 - 12/2015
2	regorafenibIBA 10/2020 - 02/2018
2	Cytotoxins (Cytolysins)IBA 07/2020 - 08/2015
2	Sunitinib (Sutent)FDA Link 06/2019 - 10/2013
2	Amylases FDA Link 01/2019 - 03/2014
2	Indicators and Reagents (Reagents)IBA 10/2018 - 01/2016
2	Carcinoembryonic AntigenIBA 08/2018 - 09/2004
2	trametinibIBA 08/2018 - 01/2018
2	N-formylmethionylphenylalanine (FMP)IBA 06/2017 - 02/2005
2	Biological ProductsIBA 08/2015 - 03/2014
2	Etoposide (VP 16)FDA LinkGeneric 08/2015 - 04/2010
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2014 - 02/2011
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2014 - 02/2011
2	Angiogenesis InhibitorsIBA 10/2014 - 02/2011
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2012 - 10/2006
2	Tyrosine Kinase InhibitorsIBA 09/2012 - 02/2011
2	S 1 (combination)IBA 04/2012 - 12/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2011 - 12/2010
2	Transaminases (Aminotransferases)IBA 01/2007 - 01/2005
1	PlasticsIBA 12/2022
1	Diazepam (Valium)FDA LinkGeneric 09/2022
1	atezolizumabIBA 09/2022
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 07/2022
1	futibatinibIBA 07/2022
1	trastuzumab deruxtecanIBA 06/2022
1	DiamondIBA 05/2022

Therapy/Procedure

57	Drug Therapy (Chemotherapy) 02/2022 - 01/2005
34	Therapeutics 09/2022 - 01/2005
9	Combination Drug Therapy (Combination Chemotherapy) 02/2022 - 01/2005
4	Stents 12/2022 - 09/2020
2	Self Expandable Metallic Stents 12/2022 - 04/2022
2	Radiotherapy 09/2017 - 01/2005
2	Oral Administration 02/2016 - 04/2014
2	Chemoradiotherapy 12/2012 - 01/2005
2	Intravenous Infusions 08/2010 - 02/2005
2	Palliative Care (Palliative Therapy) 04/2008 - 01/2006
1	Choledochostomy 04/2022